CURRICULUM VITAE - VA Surgeons

A Phase 2B, Randomized Multicenter, Dose-Ranging Study Assessing the Safety and Efficacy of PD 0348292 in the Prevention of Venous Thromboembolic Events (VTE) in Subjects Undergoing an Elective, Unilateral Total Knee Replacement. (Protocol A5571010) Pfizer, Inc., 2007. ................
................